Breaking News

Cambridge Major Appoints SciTech VP

November 27, 2012

Raje to provide strategic leadership for API organization

Dr. Prasad Raje has been appointed vice president of science and technology at Cambridge Major Laboratories. Dr. Raje will provide technical and strategic leadership and will have overall responsibility for the company’s API development organization. He will also play a key role in implementing new technologies and services.
Dr. Raje has more than 15 years of pharmaceutical industry experience and a track record of providing substantial organizational growth. He previously served as president of Smithers Pharma Services, a CRO with expertise in analytical services, pharmaceutical R&D, and agrochemicals. Dr. Raje also held positions with AMRI, initially as section head, chemical development, and later as president and managing director of AMRI India.  
“Dr. Raje brings a proven track record of solving the most complex chemistry challenges relating to the development of APIs, solid state chemistry, formulation development, and analytical chemistry,” said Brian Scanlan, president and chief executive officer of CML. “His in-depth knowledge across the entire drug development process will help guide our clients’ development programs from early pre-clinical through to commercialization, said Scanlan. His passion for chemistry will expand our culture of innovation and technical excellence, cementing our leading position in the industry.”

Related Contract Manufacturing:

  • Analytical Testing Outsourcing Trends Update

    Analytical Testing Outsourcing Trends Update

    January 26, 2017
    Spurred by many factors, global analytical testing services market is experiencing rapid growth in the range of 11% per year

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus